BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24473199)

  • 21. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
    Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
    Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
    Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
    Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
    Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
    Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
    Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
    Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soy Isoflavone Protects Myocardial Ischemia/Reperfusion Injury through Increasing Endothelial Nitric Oxide Synthase and Decreasing Oxidative Stress in Ovariectomized Rats.
    Tang Y; Li S; Zhang P; Zhu J; Meng G; Xie L; Yu Y; Ji Y; Han Y
    Oxid Med Cell Longev; 2016; 2016():5057405. PubMed ID: 27057277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.
    Imanishi T; Tsujioka H; Ikejima H; Kuroi A; Takarada S; Kitabata H; Tanimoto T; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertension; 2008 Sep; 52(3):563-72. PubMed ID: 18645051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival kinase-dependent pathways contribute to gender difference in the response to myocardial ischemia-reperfusion and ischemic post-conditioning.
    Ciocci Pardo A; Scuri S; González Arbeláez LF; Caldiz C; Fantinelli J; Mosca SM
    Cardiovasc Pathol; 2018; 33():19-26. PubMed ID: 29414428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
    Koid SS; Ziogas J; Campbell DJ
    Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
    Itoh T; Haruna M; Abe K
    Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.
    Liu Y; Jin J; Qiao S; Lei S; Liao S; Ge ZD; Li H; Wong GT; Irwin MG; Xia Z
    Clin Sci (Lond); 2015 Aug; 129(4):331-44. PubMed ID: 25849791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
    Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling.
    Raphael J; Gozal Y; Navot N; Zuo Z
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):348-57. PubMed ID: 20125034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.
    Li XD; Yang YJ; Geng YJ; Zhao JL; Zhang HT; Cheng YT; Wu YL
    Acta Pharmacol Sin; 2012 Jul; 33(7):879-87. PubMed ID: 22659627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone Ameliorates Myocardial Ischemia/Reperfusion Injury in Rat by Inhibiting Apoptosis and Autophagy Via the PI3K-Akt Signal Pathway.
    Xuan F; Jian J; Lin X; Huang J; Jiao Y; Huang W; Li J; Shi Z; Huang R
    Cardiovasc Toxicol; 2017 Jan; 17(1):79-87. PubMed ID: 26792585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aliskiren reduces portal pressure in portal hypertensive rats.
    Chang CC; Lee WS; Huang HC; Lee FY; Wang SS; Lin HC; Nong JY; Lee SD
    Eur J Clin Invest; 2012 May; 42(5):526-33. PubMed ID: 22023532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury.
    Wildhirt SM; Weismueller S; Schulze C; Conrad N; Kornberg A; Reichart B
    Cardiovasc Res; 1999 Aug; 43(3):698-711. PubMed ID: 10690341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.